Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics Acquires Spatial Transcriptomics

NEW YORK (GenomeWeb) — 10x Genomics said today that it has acquired Spatial Transcriptomics, a Swedish developer of two-dimensional gene expression technology for tissue sample sections, for an undisclosed amount.

Spatial Transcriptomics' technology, originally developed at the Science for Life Laboratory in Stockholm, combines histology and gene-expression analysis by sequencing cDNA libraries created from transcripts obtained from specific locations in a tissue sample by array-based capture probes. It has also developed software to visualize gene expression and morphology data.

10x Genomics said it will retain Spatial Transcriptomics' team at the company's existing offices in Stockholm. Additional terms of the deal were not disclosed.

"Now, researchers will not only be able to understand what is happening within a cell but also understand where cellular activities are happening in relation to one another," 10x Genomics Cofounder and CEO Serge Saxonov said in a statement. "It's another integral piece of the puzzle that gets us closer to seeing the whole picture of biology to drive new discoveries."

Earlier this year, Pleasanton, California-based 10x Genomics acquired Stanford University spinout Epinomics, which is developing technology for mapping chromatin regions across the genome. It also recently partnered with BioLegend and Immudex on applications for its barcoding technology.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more